{
    "uniprot_canonical_ac": "A0A0G2JX94-1",
    "uniprot_id": [
        {
            "id": "A0A0G2JX94_RAT",
            "url": "https://www.uniprot.org/uniprot/A0A0G2JX94_RAT",
            "type": "external"
        }
    ],
    "mass": 121989.0,
    "length": 1142,
    "protein_name": "Angiomotin",
    "gene_name": "Amot",
    "organism": "Rat",
    "refseq_name": "angiomotin isoform 1",
    "refseq_ac": [
        {
            "id": "NP_001419809",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001419809",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "Amot",
    "gene_names_refseq": "Amot; RGD1564027",
    "protein_names_uniprotkb": "Angiomotin",
    "protein_names_refseq": "angiomotin isoform 1",
    "tax_id": 10116,
    "disease": "",
    "pathway": " (R-RNO-2028269);  (R-RNO-9762292)",
    "pathway_count": 2,
    "publication_count": 4,
    "publication_id_list": "29317530;30039887;31325776;31940260",
    "function": "AMOT130 linking F-actin to YAP is involved in intervertebral disc degeneration, [RefSeq, PubMed]; AMOT130/YAP mechanotransduction pathway plays a major role in topography-induced bone marrow mesenchymal stem cells osteoblastic differentiation., [RefSeq, PubMed]; Angiomotin links ROCK and YAP signaling in mechanosensitive differentiation of neural stem cells., [RefSeq, PubMed]; The AMOT-130 is essential for normal spine morphogenesis and identifies Lats1 as an upstream regulator in this process. Moreover, It findings may link AMOT-130 loss and the related spine defects to neurological disorders., [RefSeq, PubMed]",
    "predicted_glycosites": 7,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 7,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 7,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 0,
    "glyco_site_count": 7,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0042802 identical protein binding;GO:0043532 angiostatin binding;GO:0038023 signaling receptor activity",
    "go_cellular_component": "GO:0098978 glutamatergic synapse;GO:0005884 actin filament;GO:0005886 plasma membrane;GO:0005923 bicellular tight junction;GO:0014069 postsynaptic density",
    "go_biological_process": "GO:0000122 negative regulation of transcription by RNA polymerase II;GO:0001525 angiogenesis;GO:0001570 vasculogenesis;GO:0001701 in utero embryonic development;GO:0006935 chemotaxis",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0G2JX94-1",
    "record_type": "protein",
    "filter_code": "0000000.0000101.010000.0000000000001000.00010.001"
}